Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Pathogenesis of HCC Driven by NASH and the Preventive and Therapeutic Effects of Natural Products
Gaoxuan Shao, Ying Liu, Lu Lu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20

Showing 20 citing articles:

Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment
Xiangyu Guo, Xunzhe Yin, Zuojia Liu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15489-15489
Open Access | Times Cited: 180
The Influence of Sex Hormones in Liver Function and Disease
Alvile Kasarinaite, Matthew C. Sinton, Philippa T. K. Saunders, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1604-1604
Open Access | Times Cited: 48
Therapeutic potential of traditional Chinese medicine in the prevention and treatment of digestive inflammatory cancer transformation: Portulaca oleracea L. as a promising drug
Gaoxuan Shao, Ying Liu, Lu Lu, et al.
Journal of Ethnopharmacology (2024) Vol. 327, pp. 117999-117999
Open Access | Times Cited: 17
Metabolic Dysfunction-Associated Steatohepatitis and Progression to Hepatocellular Carcinoma: A Literature Review
Haider Ghazanfar, Nismat Javed, Abeer Qasim, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1214-1214
Open Access | Times Cited: 13
Inhibition of Lipid Accumulation and Oxidation in Hepatocytes by Bioactive Bean Extracts
Dya Fita Dibwe, E. Kitayama, Saki Oba, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 513-513
Open Access | Times Cited: 3
A mini-review on prebiotic inulin to prevent and treat non-alcoholic fatty liver disease
Nelson Kei, Susana Lauw, Vincent Wai‐Sun Wong, et al.
Food Bioscience (2024) Vol. 61, pp. 104679-104679
Closed Access | Times Cited: 3
Impact of gut microbiota on metabolic dysfunction-associated steatohepatitis and hepatocellular carcinoma: pathways, diagnostic opportunities and therapeutic advances
Ayana R. Kumar, Bhagyalakshmi Nair, Adithya Jayaprakash Kamath, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 3
Metabolic Risk Factors for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: A Prospective Study
Samuel O. Antwi, Emily C. Craver, Yvonne Ayerki Nartey, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6234-6234
Open Access | Times Cited: 14
Molecular Genealogy of Metabolic-associated Hepatocellular Carcinoma
Takahiro Kodama, Tetsuo Takehara
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 147-158
Open Access | Times Cited: 2
Application and mechanism of Chinese herb medicine in the treatment of non-alcoholic fatty liver disease
Yuqiao Liu, Yue Fan, Ji‐Bin Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Insights into the role of vitamin D in targeting the culprits of non-alcoholic fatty liver disease
Basma A. Abdelrahman, Aiman S. El‐Khatib, Yasmeen M. Attia
Life Sciences (2023) Vol. 332, pp. 122124-122124
Closed Access | Times Cited: 6
Risk of Hepatocellular Carcinoma with Glucagon-like Peptide-1 receptor agonist treatment in patients: a systematic review and meta-analysis
Muhammed Shabil, Mahalaqua Nazli Khatib, Suhas Ballal, et al.
BMC Endocrine Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Is Fasting Good When One Is at Risk of Liver Cancer?
Iulia Minciună, Laurens A. van Kleef, Horia Ştefănescu, et al.
Cancers (2022) Vol. 14, Iss. 20, pp. 5084-5084
Open Access | Times Cited: 7
Apoptosis antagonizing transcription factor‐mediated liver damage and inflammation to cancer: Therapeutic intervention by curcumin in experimental metabolic dysfunction associated steatohepatitis‐hepatocellular carcinoma
Akshatha N. Srinivas, Diwakar Suresh, Saravana Babu Chidambaram, et al.
Journal of Cellular Physiology (2023) Vol. 239, Iss. 1
Closed Access | Times Cited: 3
Pathogenesis to management of hepatocellular carcinoma
Ben L. Da, Aiwu Ruth He, Kirti Shetty, et al.
Genes & Cancer (2022) Vol. 13, pp. 72-87
Open Access | Times Cited: 5
A herb mixture to ameliorate non-alcoholic fatty liver in rats fed a high-fat diet
Sang Keun Ha, Jin-Ah Lee, Donghwan Kim, et al.
Heliyon (2023) Vol. 9, Iss. 8, pp. e18889-e18889
Open Access | Times Cited: 2
Surgical Implications for Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma
Centura R. Anbarasu, Sophia Williams‐Perez, E. Ramsay Camp, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2773-2773
Open Access
Unveiling functionality and conducting two-sample mendelian randomization on WGCNA-identified oxidative stress-related hub genes in metabolic dysfunction-associated fatty liver disease
Qian Zhu, Jiaqi Liu, Wuxuan Mei, et al.
Biochemistry and Biophysics Reports (2024) Vol. 40, pp. 101829-101829
Open Access
Management of non-alcoholic fatty liver disease-associated hepatocellular carcinoma
Peijun Xu, M. Liu, Miao Liu, et al.
BioScience Trends (2024)
Open Access
AATF-mediated Liver Damage and Inflammation to Cancer: Therapeutic Intervention by Curcumin in Experimental MASH-HCC
Akshatha N. Srinivas, Diwakar Suresh, Saravana Babu Chidambaram, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top